|
1
|
Konishi T, Watanabe T, Kishimoto J, Kotake
K, Muto T and Nagawa H: Japanese Society for Cancer of the Colon
and Rectum: Prognosis and risk factors of metastasis in colorectal
carcinoids: Results of a nationwide registry over 15 years. Gut.
56:863–868. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Konishi T, Watanabe T, Muto T, Kotake K
and Nagawa H: Japanese Society for Cancer of the Colon and Rectum:
Site distribution of gastrointestinal carcinoids differs between
races. Gut. 55:1051–1052. 2006.PubMed/NCBI
|
|
3
|
Konishi T, Watanabe T, Nagawa H, Oya M,
Ueno M, Kuroyanagi H, Fujimoto Y, Akiyoshi T, Yamaguchi T and Muto
T: Treatment of colorectal carcinoids: A new paradigm. World J
Gastrointest Surg. 2:153–156. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rindi G, Arnold R and Bosman F:
Nomenclature and classification of neuroendocrine neoplasms of the
digestive systemBosman FT, Carneiro F and Hruban RH: WHO
Classification of Tumours of the Digestive System. IARC Press;
Lyon: 2010
|
|
5
|
Hamilton SR and Aaltonen LA: World Health
Organization, International Agency for Research on Cancer.
Pathology and genetics of tumours of the digestive system. IARC
Press; Lyon: pp. 105–111. 2000
|
|
6
|
Pelosi G, Bresaola E, Bogina G, Pasini F,
Rodella S, Castelli P, Iacono C, Serio G and Zamboni G: Endocrine
tumors of the pancreas: Ki-67 immunoreactivity on paraffin sections
is an independent predictor for malignancy: A comparative study
with proliferating-cell nuclear antigen and progesterone receptor
protein immunostaining, mitotic index, and other clinicopathologic
variables. Hum Pathol. 27:1124–1134. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vilar E, Salazar R, Pérez-Garcia J, Cortes
J, Oberg K and Tabernero J: Chemotherapy and role of the
proliferation marker Ki-67 in digestive neuroendocrine tumors.
Endocr Relat Cancer. 14:221–232. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Klöppel G, Perren A and Heitz PU: The
gastroenteropancreatic neuroendocrine cell system and its tumors:
The WHO classification. Ann N Y Acad Sci. 1014:13–27. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Modlin IM, Kidd M, Latich I, Zikusoka MN
and Shapiro MD: Current status of gastrointestinal carcinoids.
Gastroenterology. 128:1717–1751. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ito T, Tanaka M, Sasano H, Osamura YR,
Sasaki I, Kimura W, Takano K, Obara T, Ishibashi M, Nakao K, et al:
Preliminary results of a Japanese nationwide survey of
neuroendocrine gastrointestinal tumors. J Gastroenterol.
42:497–500. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Soga J: Endocrinocarcinomas (carcinoids
and their variants) of the duodenum. An evaluation of 927 cases. J
Exp Clin Cancer Res. 22:349–363. 2003.PubMed/NCBI
|
|
12
|
Soga J: Carcinids and their variant
endocrinomas. An analysis of 11842 reported cases. J Exp Clin
Cancer Res. 22:517–530. 2003.PubMed/NCBI
|
|
13
|
Soga J: Carcinoids of the rectum: An
evaluation of 1271 reported cases. Surg Today. 27:112–119. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Soga J: Gastric carcinoids: A statistical
evaluation of 1,094 cases collected from the literature. Surg
Today. 27:892–901. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Soga J: Carcinoids of the small intestine:
A statistical evaluation of 1102 cases collected from the
literature. J Exp Clin Cancer Res. 16:353–363. 1997.PubMed/NCBI
|
|
16
|
Fahy BN, Tang LH, Klimstra D, Wong WD,
Guillem JG, Paty PB, Temple LK, Shia J and Weiser MR: Carcinoid of
the rectum risk stratification (CaRRS): A strategy for preoperative
outcome assessment. Ann Surg Oncol. 14:396–404. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fahy BN, Tang LH, Klimstra D, Wong WD,
Guillem JG, Paty PB, Temple LK, Shia J and Weiser MR: Carcinoid of
the rectum risk stratification (CaRRs): A strategy for preoperative
outcome assessment. Ann Surg Oncol. 14:1735–1743. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tanaka S, Oka S, Kaneko I, Hirata M, Mouri
R, Kanao H, Yoshida S and Chayama K: Endoscopic submucosal
dissection for colorectal neoplasia: Possibility of
standardization. Gastrointest Endosc. 66:100–107. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sakata H, Iwakiri R, Ootani A, Tsunada S,
Ogata S, Ootani H, Shimoda R, Yamaguchi K, Sakata Y, Amemori S, et
al: A pilot randomized control study to evaluate endoscopic
resection using a ligation device for rectal carcinoid tumors.
World J Gastroenterol. 12:4026–4028. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nagai T, Torishima R, Nakashima H,
Ookawara H, Uchida A, Kai S, Sato R, Murakami K and Fujioka T:
Saline-assisted endoscopic resection of rectal carcinoids: Cap
aspiration method versus simple snare resection. Endoscopy.
36:202–205. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hasegawa T, Matsuno Y, Shimoda T and
Hirohashi S: Gastrointestinal stromal tumor: Consistent CD117
immunostaining for diagnosis, and prognostic classification based
on tumor size and MIB-1 grade. Hum Pathol. 33:669–676. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yamaguchi T, Fujimori1 T, Tomita S,
Ichikawa K, Mitomi H, Ohno K, Shida Y and Kato H: Clinical
validation of the gastrointestinal NET grading system: Ki67 index
criteria of the WHO 2010 classification is appropriate to predict
metastasis or recurrence. Diagn Pathol. 8:652013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mani S, Modlin IM, Ballantyne G, Ahlman H
and West B: Carcinoids of the rectum. J Am Coll Surg. 179:231–248.
1994.PubMed/NCBI
|
|
24
|
Fujimoto Y, Oya M, Kuroyanagi H, Ueno M,
Akiyoshi T, Yamaguchi T and Muto T: Lymph-node metastases in rectal
carcinoids. Langenbecks Arch Surg. 395:139–142. 2010. View Article : Google Scholar : PubMed/NCBI
|
